Pulmonary Bleeding During Right Ventricular Support After Left Ventricular Assist Device Implantation

Area of Science:

• Cardiology
• Cardiovascular Surgery
• Medical Device Technology

Background:

• Right heart failure is a significant complication following left ventricular assist device (LVAD) implantation, affecting up to 20% of patients.
• Temporary right ventricular assist devices (RVADs) are used to manage this complication.
• Non-pulsatile lung perfusion from RVADs may increase the risk of pulmonary hemorrhage.

Purpose of the Study:

• To determine the incidence of pulmonary bleeding complications in patients requiring temporary RVAD support after LVAD implantation.
• To identify risk factors associated with pulmonary bleeding in this patient population.

Main Methods:

• An observational study was conducted at a single university hospital.
• Twenty-five patients who underwent LVAD implantation followed by temporary RVAD implantation were screened for pulmonary bleeding.
• Pulmonary bleeding was diagnosed using computed tomography scans and bronchoscopy.

Main Results:

• Five patients (20%) developed pulmonary bleeding complications.
• Bleeding events occurred after postoperative day 7.
• Complications were associated with RVAD flow rates greater than 4 L/min within 24 hours preceding the event.

Conclusions:

• Temporary RVAD support exceeding 7 days and blood flow greater than 4 L/min are associated with pulmonary bleeding.
• These factors should be considered when planning temporary RVAD support after LVAD implantation.
• Further research may be warranted to optimize RVAD management and minimize bleeding risks.